CLINICAL_TRIALS
trial_result
· 2026-08-05
Clinical Trial Results: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis [Phase 2]
Summary
Phase 2 randomized, double-blind trial of Bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis has terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pliant Therapeutics, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: TERMINATED | Results posted: 2026-08-05